Searched for
NPPA PRICE CAP
India raises price cap on cancer drugs to tackle shortageIndia's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused b...- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- NPPA extends price cap on knee implants by a yearIndia's drug pricing regulator has extended the price cap on knee implants. This decision will continue to benefit patients by keeping cost...
- Knee implant ceiling rates to be reviewedNext week, the National Pharmaceutical Pricing Authority (NPPA) of India will delve into the pricing caps for knee implants, a move that pr...
- Government caps trade margin on pulse oximeter, nebuliser, digital thermometer at 70 percentThe National Pharmaceuticals Pricing Authority (NPPA) has invoked extraordinary powers under the Paragraph 19 of DPCO, 2013, to put a cap o...
- NPPA caps price of liquid medical oxygen, medical oxygen cylindersThe Empowered Group 2 also requested NPPA to consider a cap for ex-factory price of oxygen in cylinders in order to ensure supply of oxygen...
- The tightrope walk of India's drug-price regulatorET Online retraces here the tenures of NPPA chiefs. The question to ask: Is taking on the pharma and healthcare lobby injurious to the NPPA...
- Fearing more price control, medical device companies propose government to voluntarily cut pricesSeeking to preempt further govt intervention, an association representing medical companies, has asked NPPA to limit trade margins of devic...
- NPPA threatens legal action against 40 hospitals for not displaying knee implant pricesThe drug pricing watchdog has threatened action against these hospitals, which were expected to make the revised prices available online so...
- Cipla plea in High Court against change in price of asthma drugsCipla claimed that the price of the powdered form of its three asthma drugs were capped without following the proper procedure prescribed u...
- NPPA asks hospitals, doctors to report stents shortageThe regulator has been taking several steps to ensure stents are available under its prescribed price list as reports emerged that there we...
- NPPA sends show cause notices to hospitals over stent overpricing allegationsThese show cause notices have been sent after preliminary investigations into these allegations, the regulator disclosed on its official ac...
- Max Healthcare, Lilavati deny overcharging on stentsWe have not overcharged even a single patient for stent. We have complied fully and immediately with the NPPA order on stent pricing, a Max...
- NPPA warns stent makers, importers against shortageLast week, the government had slashed prices of stents by up to 85 per cent by capping them at Rs 7,260 for bare metal ones and Rs 29,600 f...
- More essential medicines to become cheaper with NPPA’s latest notificationNPPA has capped prices of nine scheduled drugs and revised the prices of 34. It has also fixed the prices of 11 retail formulations, includ...
- How are you capping drug prices in absence of guidelines: High Court to NPPAThe NPPA had on the basis of the May 29 guideline issued a notification on July 10 capping prices of 108 anti-diabetic and cardiovascular d...
- NPPA powers not withdrawn, says GovernmentGovt said it has not withdrawn powers delegated to NPPA but only internal guidelines issued by the drug price regulator to cap prices of no...
- Gujarat HC stays NPPA order to cut price of Cadila drug EnvasThe Gujarat HC has stayed a decision of the drug price regulator National Pharmaceutical Pricing Authority to lower the price of Ahmedabad-...
Load More
